Back

Cross-scale prediction of glioblastoma MGMT methylation status based on deep learning combined with magnetic resonance images and pathology images

2025-05-08 radiology and imaging Title + abstract only
View on medRxiv
Show abstract

BackgroundIn glioblastoma (GBM), promoter methylation of the O6-methylguanine-DNA methyltransferase (MGMT) is associated with beneficial chemotherapy but has not been accurately evaluated based on radiological and pathological sections. To develop and validate an MRI and pathology image-based deep learning radiopathomics model for predicting MGMT promoter methylation in patients with GBM. MethodsA retrospective collection of pathologically confirmed isocitrate dehydrogenase (IDH) wild-type GBM ...

Predicted journal destinations